To amend the Federal Food, Drug, and Cosmetic Act regarding the list under section 505(j)(7) of the Federal Food, Drug, and Cosmetic Act, and for other purposes.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for Illinois's 2nd congressional district. Democrat.
Last Updated: May 9, 2019
Length: 9 pages
What legislators are saying
“U.S. House Passes Rep. Kellys Bill to Increase Access to Lower-Cost Generic Drugs”
— Rep. Robin Kelly [D-IL2] (Sponsor) on May 8, 2019
What stakeholders are saying
H.R. 1503 is a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2019). H.R. 1503 — 116th Congress: Orange Book Transparency Act of 2019. Retrieved from https://www.govtrack.us/congress/bills/116/hr1503
“H.R. 1503 — 116th Congress: Orange Book Transparency Act of 2019.” www.GovTrack.us. 2019. September 23, 2019 <https://www.govtrack.us/congress/bills/116/hr1503>
Orange Book Transparency Act of 2019, H.R. 1503, 116th Cong..
|title=H.R. 1503 (116th)
|accessdate=September 23, 2019
|author=116th Congress (2019)
|date=March 5, 2019
|quote=Orange Book Transparency Act of 2019
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.